Your session is about to expire
← Back to Search
Mindfulness-Based Relapse Prevention for Opioid Use Disorder
Study Summary
This trial will investigate whether an adjunctive treatment of mindfulness-based relapse prevention improves outcomes of medication assisted treatment for opioid use disorder patients, including reducing drug use.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What is the overall participant count for this research endeavor?
"Affirmative, clinicaltrials.gov states that this study is still recruiting participants as of September 11th 2021. It was first posted on August 1st and seeks to enrol 200 individuals from one medical site."
What is the overarching goal of this experiment?
"The primary objective of this research is to measure the adherence to Medication Assisted Treatment (MAT) for participants 3 months after leaving a residential addiction treatment facility. Secondary objectives will be determined by assessing Dispositional Mindfulness with Feldman's Cognitive and Affective Mindfulness Scale, measuring MBRP Treatment Adherence through data on homework completion, as well as gauging Patient Reported Outcomes - Mental health with Cella et al.'s Patient-Reported Outcome Measurement Information System. Scores from these assessment tools range between 10 and 40 in terms of mindfulness, 4 and 20 regarding mental health, allowing researchers to track changes before, during and"
Are there any vacancies within this research program for prospective participants?
"As per clinicaltrials.gov, this research project is recruiting participants as we speak. The initial post date was August 1st 2021 and the latest update occurred on September 11th 2021."
Share this study with friends
Copy Link
Messenger